Can a ginkgo pill slow Alzheimer's? new trial aims to find out
NCT ID NCT07287852
First seen Jan 09, 2026 · Last updated May 17, 2026 · Updated 16 times
Summary
This study tests whether a drug made from Ginkgo Biloba extract (Egb761) can lower a key Alzheimer's-related protein in the blood of people with mild cognitive impairment. About 50 participants will take the drug twice daily for 6 months and have regular checkups. The goal is to see if the treatment can reduce signs of brain disease and improve thinking and daily function.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE (AD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hadassah medical Center
Jerusalem, 91120, Israel
Conditions
Explore the condition pages connected to this study.